Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1087057109335324v1
14/5/468    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Eriksson, H.
Right arrow Articles by Becker, B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eriksson, H.
Right arrow Articles by Becker, B.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DIMETHYL SULFOXIDE
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Validation of Low-Volume 1536-Well Assay-Ready Compound Plates

Hans Eriksson

Lead Generation Department, AstraZeneca R&D Mölndal, Sweden

Johan Brengdahl

Lead Generation Department, AstraZeneca R&D Mölndal, Sweden

Petter Sandström

Lead Generation Department, AstraZeneca R&D Mölndal, Sweden

Mattias Rohman

Lead Generation Department, AstraZeneca R&D Mölndal, Sweden

Bruno Becker

Lead Generation Department, AstraZeneca R&D Mölndal, Sweden, bruno.becker{at}astrazeneca.com

Assay-ready compound plates (ARPs) are sealed assay plates that contain DMSO solutions of screening compounds predispensed for particular assays. Assays are started by adding assay buffer and reagents to the ARPs. This concept offers important logistical advantages for screening such as decoupling of the plate preparation from the screening process and exchange of assay plates between different geographical locations. Compound solutions can be accurately and precisely dispensed by acoustic droplet ejection technology in the small volumes required for screening in the 1536-well format. At such low volumes, however, potential effects such as solvent evaporation, compound degradation, precipitation, or adsorption are reasons for concern with regard to assay reproducibility, performance, and shelf life of ARPs. To address these concerns, the authors screened freshly prepared ARPs using several types of assays. The results were compared to results obtained from plates stored for up to 13 days under 2 storage conditions (22 °C, —18 °C). Tight correlations between results were found that indicated that temperature and time had very little influence on the assay performance for up to about 1 week storage time of the plates. In addition, using a time series of microphotographs of DMSO droplets, the authors visually confirmed that the sizes of the droplets in ARPs apparently do not change over 13 days under certain storage conditions.

Key Words: nanoliter dispensing • acoustic droplet ejection technology • compound storage • compound reconstitution • 1536-well screening format

This version was published on June 1, 2009

Journal of Biomolecular Screening, Vol. 14, No. 5, 468-475 (2009)
DOI: 10.1177/1087057109335324
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?